MICHELLE DAVIS: Open Payments
NPI 1588106678 · CHARLESTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 15 payments from 7 companies in 2025. Trend: 2023 $159 · 2024 $159 · 2025 $377
Food & beverage: $374Education: $3
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $161 |
| Medline Industries LP | 1 | $81 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Novo Nordisk Inc | 1 | $26 |
| Amgen Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 2 | $3 |
Products named: Kerendia, FARXIGA, Wegovy, TAVNEOS, Filspari.
Industry payments across AR — which companies pay providers there.
